Scroll

hexamethonium 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
quaternary ammonium compounds	1366	60-26-4

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: hexamethonium benzohexamethonium hexamethone hexanium hexathonide hexamethonium bromide hexamethonium dibromide hexamethonium dibromide dihydrate	A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool. Molecular weight: 202.39 Formula: C12H30N2 CLOGP: -9.09 LIPINSKI: 0 HAC: 2 HDO: 0 TPSA: ALOGS: -7.09 ROTB: 7

Molecule

Description

Molfile Inchi Smiles

Synonyms:

hexamethonium
benzohexamethonium
hexamethone
hexanium
hexathonide
hexamethonium bromide
hexamethonium dibromide
hexamethonium dibromide dihydrate

A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Molecular weight: 202.39
Formula: C12H30N2
CLOGP: -9.09
LIPINSKI: 0
HAC: 2
HDO: 0
TPSA:
ALOGS: -7.09
ROTB: 7

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
MeSH PA	D000959	Antihypertensive Agents
MeSH PA	D002317	Cardiovascular Agents
MeSH PA	D018678	Cholinergic Agents
MeSH PA	D018680	Cholinergic Antagonists
MeSH PA	D005730	Ganglionic Blockers
MeSH PA	D018377	Neurotransmitter Agents
MeSH PA	D018733	Nicotinic Antagonists
MeSH PA	D018373	Peripheral Nervous System Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Bioact source
Neuronal acetylcholine receptor; alpha4/beta2	Ion channel	P17787 P43681	ACHB2_HUMAN ACHA4_HUMAN		IC50	4.54	CHEMBL
Neuronal acetylcholine receptor; alpha4/beta4	Ion channel	P30926 P43681	ACHB4_HUMAN ACHA4_HUMAN		IC50	4.04	CHEMBL
Neuronal acetylcholine receptor subunit alpha-4	Ion channel	P43681	ACHA4_HUMAN	BLOCKER	IC50	5.17	IUPHAR
Neuronal acetylcholine receptor subunit alpha-6	Ion channel	Q15825	ACHA6_HUMAN	BLOCKER	IC50	4.04	IUPHAR
Neuronal acetylcholine receptor; alpha4/beta2	Ion channel		ACHA4_RAT ACHB2_RAT		Ki	4.66	CHEMBL
Acetylcholine receptor	Ion channel		ACHA_TORCA ACHB_TORCA ACHG_TORCA ACHD_TORCA		Kd	5.74	CHEMBL

External reference:

ID	Source
D02204	KEGG_DRUG
55-97-0	SECONDARY_CAS_RN
C0062637	UMLSCUI
CHEBI:5700	CHEBI
CHEMBL105608	ChEMBL_ID
CHEMBL100622	ChEMBL_ID
DB08960	DRUGBANK_ID
CHEMBL2106122	ChEMBL_ID
D018738	MESH_DESCRIPTOR_UI
3604	PUBCHEM_CID
3963	IUPHAR_LIGAND_ID
3C9PSP36Z2	UNII
001772	NDDF
004717	NDDF
49839002	SNOMEDCT_US
CHEMBL332524	ChEMBL_ID
2047	INN_ID

Pharmaceutical products:

None